- Home
- PSTV vs EKSO Comparison
PSTV vs EKSO Comparison
Compare PSTV & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- EKSO
- Stock Information
- Founded
- PSTV 1996
- EKSO 2005
- Country
- PSTV United States
- EKSO United States
- Employees
- PSTV N/A
- EKSO N/A
- Industry
- PSTV Medical/Dental Instruments
- EKSO Medical/Dental Instruments
- Sector
- PSTV Health Care
- EKSO Health Care
- Exchange
- PSTV Nasdaq
- EKSO Nasdaq
- Market Cap
- PSTV 10.4M
- EKSO 11.7M
- IPO Year
- PSTV N/A
- EKSO N/A
- Fundamental
- Price
- PSTV $0.18
- EKSO $2.82
- Analyst Decision
- PSTV Strong Buy
- EKSO Strong Buy
- Analyst Count
- PSTV 3
- EKSO 2
- Target Price
- PSTV $13.00
- EKSO $37.50
- AVG Volume (30 Days)
- PSTV 13.6M
- EKSO 238.2K
- Earning Date
- PSTV 08-13-2025
- EKSO 07-28-2025
- Dividend Yield
- PSTV N/A
- EKSO N/A
- EPS Growth
- PSTV N/A
- EKSO N/A
- EPS
- PSTV N/A
- EKSO N/A
- Revenue
- PSTV $5,206,000.00
- EKSO $17,544,000.00
- Revenue This Year
- PSTV $13.26
- EKSO $0.20
- Revenue Next Year
- PSTV $8.84
- EKSO $42.29
- P/E Ratio
- PSTV N/A
- EKSO N/A
- Revenue Growth
- PSTV N/A
- EKSO N/A
- 52 Week Low
- PSTV $0.16
- EKSO $2.82
- 52 Week High
- PSTV $2.31
- EKSO $22.95
- Technical
- Relative Strength Index (RSI)
- PSTV 29.61
- EKSO 20.84
- Support Level
- PSTV $0.16
- EKSO $3.75
- Resistance Level
- PSTV $0.36
- EKSO $4.03
- Average True Range (ATR)
- PSTV 0.04
- EKSO 0.35
- MACD
- PSTV -0.00
- EKSO -0.07
- Stochastic Oscillator
- PSTV 8.38
- EKSO 0.00
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.